Search results for "Vaccines"
COVID-19 pill study; new vaccine recommendation plus data on waning efficacy, low risk of postvaccine myocarditis; updates on experimental treatments
A peer-reviewed study showed molnupiravir reduced hospitalizations and deaths in high-risk patients, the CDC favored mRNA vaccines over J&J's, experts explained potential issues with waning efficacy data, and a study quantified the low risk of myocarditis after vaccination.
https://immattersacp.org/weekly/archives/2021/12/21/1.htm
21 Dec 2021
HPV vaccine impacts disease, screening
While HPV immunization is recommended during adolescence, internists practicing in the postvaccine era have their own host of considerations: namely, screening for cervical cancer and providing catch-up vaccination.
https://immattersacp.org/archives/2017/02/hpv.htm
1 Feb 2017
Research, regulators consider booster dose of COVID-19 vaccine
FDA advisors recommended boosters for older and high-risk patients. The latest COVID-19 research looked at vaccine effectiveness, remdesivir's effects, an early indicator of vaccine-induced immune thrombotic thrombocytopenia, and rates of follow-up after hospitalization.
https://immattersacp.org/weekly/archives/2021/09/21/1.htm
21 Sep 2021
Studies look at COVID-19 vaccine boosters; ACP, Annals forum tackles challenging clinical questions
Two Israeli studies showed that vaccine boosters reduced rates of infection and severe disease. Experts gathered for the seventh ACP and Annals of Internal Medicine virtual forum on COVID-19. The FDA authorized a monoclonal antibody for pre-exposure prophylaxis in certain patients.
https://immattersacp.org/weekly/archives/2021/12/14/1.htm
14 Dec 2021
New herpes zoster vaccine brings familiar challenges
A new vaccine should be considered the preferred option for prevention of shingles in adults and should be given in place of the existing one, but it brings with it familiar considerations: efficacy, insurance, and patient communication.
https://immattersacp.org/archives/2018/02/new-herpes-zoster-vaccine-brings-familiar-challenges.htm
1 Feb 2018
Studies find monoclonal antibodies and remdesivir effective, while vaccine-associated myocarditis is rare
A trial of casirivimab plus imdevimab indicated it reduced risk of hospitalization or death, the CDC urged vaccination during pregnancy and updated its v-safe tool, and an analysis showed that postvaccine myocarditis occurred in men and resolved with conservative treatment.
https://immattersacp.org/weekly/archives/2021/10/05/1.htm
5 Oct 2021
Oral drug for postpartum depression approved
This column reviews recent recalls, alerts, and approvals.
https://immattersacp.org/archives/2023/10/oral-drug-for-postpartum-depression-approved.htm
1 Oct 2023
Regulatory changes for COVID-19 vaccine; data on waning immunity, outpatient therapies
The FDA authorized vaccinating children, the NIH supported concurrent use of flu and COVID-19 shots, and the CDC addressed a fourth dose of COVID-19 vaccine for the immunocompromised. Trials found benefit from a new monoclonal antibody and an old antidepressant for high-risk outpatients.
https://immattersacp.org/weekly/archives/2021/11/02/1.htm
2 Nov 2021
Pneumococcal vaccine recommendations can be unclear
While most physicians surveyed about current Advisory Committee on Immunization Practices (ACIP) recommendations responded that they found them to be very clear or somewhat clear, when tested with questions about the recommendations and several case scenarios, many of the survey respondents answered incorrectly.
https://immattersacp.org/archives/2018/04/pneumococcal-vaccine-recommendations-can-be-unclear.htm
1 Apr 2018
‘Facts are stubborn things' and are needed more than ever
ACP advocacy is based on the premise that public policy positions that are well supported by facts and evidence will be more persuasive and have greater acceptance.
https://immattersacp.org/archives/2017/03/washington.htm
1 Mar 2017